14 Results for "

Gz

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "Gz" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-16743
CAS No.: 1401090-53-6
Synonyms: Venglustat; SAR402671; Gz402671
Research Areas:  

Metabolic Disease

Ibiglustat (Venglustat) is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16743A
CAS No.: 1629063-78-0
Synonyms: Venglustat (L-Malic acid); SAR402671 (L-Malic acid); Gz402671 (L-Malic acid)
Research Areas:  

Metabolic Disease

Ibiglustat (Venglustat) L-Malic acid is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat L-Malic acid can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16743B
CAS No.: 1629063-80-4
Synonyms: Venglustat succinate; SAR402671 succinate; Gz402671 succinate
Research Areas:  

Neurological Disease

Ibiglustat (Venglustat) succinate is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat succinate can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99635
CAS No.: 1826020-80-7
Synonyms: Gz-402668

Target:  

NF-κB

Research Areas:  

Cancer

Gatralimab (GZ-402668) is an IgG1 anti-CD52 monoclonal antibody .
loading...
    loading...
Cat. No.: HY-137677B
CAS No.: 94825-44-2
Purity:  96.04%
Synonyms: Guanosine 5'-[γ-thio]triphosphate tetralithium
Target:  

GLUT

Research Areas:  

Metabolic Disease

GTPγS (Guanosine 5'-[γ-thio]triphosphate) tetralithium is a G-protein activator that protects proteins from proteolytic degradation, stimulates GLUT4 translocation in a tyrosine kinase-dependent manner, stimulate phospholipases and induce actin polymerization. GTPγS tetralithium to couple with G- protein α, to study its effect on kinase activity. GTPγS tetralithium acts as a component of lysis buffer .
loading...
    loading...
Cat. No.: HY-D2345
GZ22-4 is a near-infrared (NIR) fluorescent probe. GZ22-4 shows high affinity for carbonic anhydrase IX (CAIX), with a Kd of 0.2 nM. GZ22-4 can be used for the research of visualize CAIX-positive tumors .
loading...
    loading...
Cat. No.: HY-117883
CAS No.: 1356447-90-9
Purity:  99.50%
Target:  

Monoamine Transporter

Research Areas:  

Neurological Disease

GZ-793A is an orally active and selective vesicular monoamine transporter-2 (VMAT2) inhibitor, with an Ki of 0.029 µM. GZ-793A inhibits the neurochemical effects of methamphetamine (METH)-induced dopamine release. GZ-793A can be used for research of METH addiction .
loading...
    loading...
Cat. No.: HY-152171
CAS No.: 2141974-01-6
Target:  

Monoamine Transporter

Research Areas:  

Neurological Disease

GZ-11608 is a potent and selective vesicular monoamine transporter-2 (VMAT2) inhibitor with high affinity (Ki = 25 nM). GZ-11608 decreases methamphetamine-induced dopamine release from isolated synaptic vesicles from brain dopaminergic neurons. GZ-11608 exhibits rapid brain penetration and without neurotoxicity. GZ-11608 can be used for the research of methamphetamine use disorder .
loading...
    loading...
Cat. No.: HY-120393
CAS No.: 1788906-96-6
Target:  

Trk Receptor

Research Areas:  

Cancer

GZ-389988 is a potent pan-TRK inhibitor with IC50 values ​​of 0.3, 0.1, and 0.5 nM for TRKA, TRKB, and TRKC, respectively. GZ-389988 can be used to study NTRK fusion-positive tumors .
loading...
    loading...
Cat. No.: HY-135228
CAS No.: 68312-88-9
Target:  

Calcium Channel

Research Areas:  

Neurological Disease

GZ4 is a calcium current inhibitor with direct inhibitory activity on cell surface channels. GZ4 inhibition reverses mechanical hyperalgesia/hyperalgesia in a spinal nerve ligation-induced neuropathic pain model. The mechanism of action of GZ4 is similar to that of gabapentin, but the time course of its biological effects is more rapid, indicating that GZ4 can directly inhibit calcium channel currents .
loading...
    loading...
Cat. No.: HY-16743C
CAS No.: 1629063-79-1
Synonyms: Venglustat hydrochloride; SAR402671 hydrochloride; Gz402671 hydrochloride
Research Areas:  

Metabolic Disease

Ibiglustat hydrochloride is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat hydrochloride can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease .
loading...
    loading...
Cat. No.: HY-150722
CAS No.: 2803866-44-4
Target:  

HDAC

Research Areas:  

Cancer

HDAC6-IN-12 (compound GZ) is a potent HDAC6 inhibitor. HDAC6-IN-12 has anticancer activity through merges into DNA strands causing DNA damage. HDAC6-IN-12 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-RS19138
Research Areas:  

Others

Gnaz Mouse Pre-designed siRNA Set A contains three designed siRNAs for Gnaz gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P72208
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Gx; alpha chain; GNAZ; GNAZ_HUMAN; Guanine nucleotide-binding protein Gz; subunit alpha; Gz-alpha
Species:  
Source:  
loading...
    loading...
  • 1